Products

ALLERGY TREATMENTS

DBV Technologies’ novel approach to allergy treatment is focused on eliciting an immune response by targeting the antigen-presenting cells in the skin epidermis. The antigens (allergens) are delivered to the skin using DBV Technologies’ unique worldwide patented delivery system, VIASKIN®.
VIASKIN® Peanut is the first peanut desensitization product ever developed for peanut allergies, a huge unmet medical need;
VIASKIN® Milk is specifically designed for patients with severe IgE-mediated milk allergies. It is the first medical desensitization product designed for cow’s milk protein allergy.
VIASKIN® in development: This technology is very versatile and could be adapted very easily to other allergens for specific geographical needs

ALLERGY Diagnosis

DBV Technologies’ novel approach to allergy diagnosis is focused on eliciting an immune response by targeting the antigen-presenting cells in the skin epidermis. The antigens (allergens) are delivered to the skin using DBV Technologies’ unique worldwide patented delivery system, VIASKIN®.
Based on the VIASKIN^® technology, DBV is developing products for the diagnosis of allergies.
Diallertest® Milk is the first “ready to use” Patch-Test for the diagnosis of cow’s milk allergy in children.
Diallertest® Milk is DBV Technologies’ first marketed product in the Diallertest^® portfolio.
Diallertest® in development: additional products are currently in development for the diagnosis of other allergies.